...
首页> 外文期刊>Journal of the American Chemical Society >A New Class of Macrocyclic Receptors from iota-Peptides
【24h】

A New Class of Macrocyclic Receptors from iota-Peptides

机译:一类新的来自iota肽的大环受体

获取原文
获取原文并翻译 | 示例
           

摘要

Macrocyclic oligomers, such as cyclodextrins, calixarenes, and porphyrins have for decades been among the preeminent receptors and catalysts of bioorganic and medicinal chemistry. These venerable macrocycles form as cyclohomooligomers via cyclooligomer-ization reactions or related processes and do not easily permit the presentation of a series of different substituents in sequence. It would be immensely challenging, if not completely impractical, to prepare a porphyrin with four different substituents in a certain order, a β-cyclodextrin with seven, or a resorc[4]arene with four. For this reason, contemporary applications of these and other important macrocycles must often be suited to symmetrical macrocycles or those bearing only one or two different substituents. This paper presents a new class of macrocycles and demonstrates the potential of these macrocycles to bind guests and display different substituents in sequence. These macrocycles are based on iota-peptides (ι-peptides) and are comparable in size to cyclodextrins, calixarenes, resorcinarenes, and porphyrins.
机译:大环低聚物,例如环糊精,杯芳烃和卟啉,几十年来一直是生物有机和药物化学的杰出受体和催化剂。这些古老的大环化合物通过环低聚物化反应或相关过程形成环高聚物,并且不容易按顺序提供一系列不同的取代基。制备具有一定顺序的四个不同取代基的卟啉,具有七个的β-环糊精或具有四个的间苯二[4]芳烃将是巨大的挑战,如果不是完全不切实际的话。因此,这些和其他重要大环的当代应用通常必须适合于对称大环或仅带有一个或两个不同取代基的大环。本文介绍了一类新的大环化合物,并证明了这些大环化合物结合客体并显示顺序不同取代基的潜力。这些大环化合物基于碘肽(α-肽),并且其大小可与环糊精,杯芳烃,间苯二酚和卟啉相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号